|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
The success of any drug counterfeit protection programme must have total agreement from two very disparate groups - corporate management and technology providers. While these two must have a happy marriage for the project to succeed, divorce is a far more common state of the relationship.
Untold hours have been spent by technology marketers preparing and making very detailed presentations to drug manufacturers. Brand managers, packaging engineers, marketing execs, legal and financial staffs - all have had the opportunity to learn and understand new anticounterfeit technologies, yet very few products bear any valid security measures.
When sales calls are followed up to determine the 'next step', most of the time the answer is the same - senior management is not interested. A huge amount of time and money can be saved if senior staff are in favour of adding anticounterfeit security to their packages. Almost all of the existing programmes originated in the 'C suite'. Top executives do not need to be involved in the selection of the fraud prevention technology, they simply have to mandate the adoption of an anticounterfeit programme and assign a senior staff member to oversee the execution of this mandate.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Inaugural Conference on Pre-Filled Syringes
21-22 January 2009, Crowne Plaza Hotel - St James, London, UK
SMi present their Inaugural Conference on Pre-Filled Syringes 21st and 22nd January 2009 at the Crowne Plaza Hotel - St James, London, UK
More info >> |
|
 |
News and Press Releases |
 |
Vindon Scientific on the Move
More info >> |
|
 |
